Hasil Pencarian  ::  Simpan CSV :: Kembali

"Penyakit kardiovaskular merupakan penyebab kematian nomor satu di dunia dengan angka kejadian yang terus bertambah. Salah satu faktor resiko dari penyakit ini adalah hipertrigliserida. Penelitian ini merupakan studi eksperimental yang ditujukan untuk mengetahui metode induksi peningkatan kadar trigliserida, dan efektifitas ekstrak buah Garcinia atroviridis sebagai antitrigliserida. Penelitian terbagi menjadi 2, pertama untuk mencari metode induksi, untuk membuktikan efektifitas ekstrak buah Garcinia atroviridis. Penelitian pertama terdiri dari kelompok tinggi lemak diberikan diet tinggi lemak (0,375ml gajih ayam, 1,5ml kuning telur puyuh, dan 1ml PTU) dan kelompok tanpa lemak diberikan diet standar dan PTU. Penelitian kedua terdiri dari kelompok uji diberikan diet tinggi lemak dengan jumlah yang sama ditambah dengan ekstrak buah Garcinia atroviridis dalam 3 dosis (10mg, 20mg, 30mg). Setiap kelompok tersebut kemudian dilakukan pemeriksaan kadar trigliserida darah. Hasilnya diuji dengan tes parametrik t-test untuk menguji metode induksi, dan one way ANOVA untuk menguji efektifitas ekstrak. Terdapat perbedaan tidak signifikan (p=0,255). Pada kelompok ekstrak didapatkan perbedaan yang signifikan pada kelompok uji 1a, dan 1c (p=0,006). Maka dapat disimpulkan bahwa terdapat efek yang signifikan dari ekstrak buah Garcinia atroviridis untuk menurunkan kadar trigliserida berdasarkan dosis pada darah tikus strain Wistar yang diberi asupan lemak berlebih.

---

Cardiovascular diseases, the world?s number one cause of death has certainly keep increasing. One of the risk factor is hypertriglyceride. This study is an experimental based study which was conducted to learn induction method to increase triglyceride level, and the effect of extract Garcinia atroviridis fruit extract as antitriglyceride.

This study was separated into 2, first to look for induction method, second to prove the effect of Garcinia atroviridis fruit extract. The first study consists of high-fat group that was given high fat diet (0,375ml fatty portion of chicken meat; 1,5ml quail's egg yolk; and 1ml PTU) and non-fat group, that was given standard diet and 1ml PTU. The second study consists of group treatments, which were given high fat diet and extract of Garcinia atroviridis fruit in 3 doses (10mg, 20mg, 30mg). Each group then examined for their triglyceride level.

The results were analyzed using t-test for induction method and one-way ANOVA test for the effect of extract There are no significance different between groups without extract (p=0,255). In groups with extract, there?s a significance difference between groups (p=0,006). Therefore it concluded that there are significance effect of Garcinia atroviridis fruit extract in reducing triglyceride level in Wistar strain rats blood."

"Penyakit kardiovaskular merupakan salah satu penyebab utama kematian di Indonesia. Low Density Lipoprotein (LDL) adalah salah satu profil lemak yang memengaruhi kejadian penyakit kardiovaskular. Penelitian ini bertujuan untuk mengetahui efek buah Garcinia atroviridis sebagai alternatif terapi untuk menurunkan kadar LDL. Penelitian ini merupakan studi eksperimental, perlakuan terhadap hewan coba tikus, dibagi dalam kelompok propylthiouracil (PTU)+diet tinggi lemak, kelompok PTU, dan pemberian 3 kelompok ekstrak. Induksi dengan asupan tinggi lemak (0,375 ml gajih ayam dan 1,5 ml kuning telur puyuh) dan PTU pada kelompok PTU+diet tinggi lemak dan 3 kelompok ekstrak. Pengambilan sampel darah pada tikus PTU dan PTU+diet tinggi lemak setelah 21 hari, dan 42 hari pada kelompok ekstrak. Data dianalisis menggunakan tes parametrik one way ANOVA dan uji T tidak berpasangan. Didapatkan rata-rata LDL tiap perlakuan: (1) PTU (24,8), (2) PTU+diet tinggi lemak (52,4), (3) dosis 10 mg (22,8), (4) dosis 20 mg (25,4), (5) dosis 30 mg (36,25). Pada uji T menunjukkan kenaikan LDL yang signifikan pasca induksi, pada uji ANOVA menunjukkan penurunan LDL pasca pemberian ekstrak buah Garcinia atroviridis yang berbeda bermakna. Analisis Post Hoc menunjukkan penurunan LDL paling signifikan pada dosis 10 mg. Disimpulkan bahwa pemberian ekstrak buah Garcinia atroviridis pada tikus strain Wistar secara signifikan menurukan kadar LDL.

---

Cardiovascular disease is one of the leading cause of death in Indonesia. Low Density Lipoprotein (LDL) is one of lipid profile that has effect on cardiovascular disease. This research is aimed to discover the effect of Garcinia atroviridis fruit extract to lower LDL level. This is an experimental study, intervention was given differently to laboratory rats: propylthiouracil (PTU)+high lipid diet, PTU, and 3 extract groups. Induction is conducted with high lipid diet (0,375 ml chicken fat and 1,5 ml quail egg yolk) and PTU, in PTU with high lipid diet and 3 extract groups. Rats blood was extracted, PTU and PTU+high lipid diet after 21 days, and 42 days for extract group.

Data was analysed using one way ANOVA parametric test and independent T test. Mean LDL value of each treatment: (1) PTU (24,8), (2) PTU+high lipid diet (52,4), (3) 10 mg (22,8), (4) 20 mg (25,4), (5) 30 mg (36,25). T test showed significant result in increasing LDL level after induction and ANOVA test showed significant result in lowering LDL level after given Garcinia atroviridis fruit extract. Post Hoc analysis shows the most significant result comes from 10 mg dose. In conclussion, Garcinia atroviridis fruit extract significantly lowers blood LDL of Wistar strain rats."

"Penyakit jantung adalah penyebab no. 1 kematian di Indonesia. Salah satu masalah utama dalam penyakit jantung adalah hipertrigliseridemia. Ekstrak kulit buah Garcinia dioica dapat menjadi salah satu terapi alternatif bagi peningkatan kadar trigliserida. Penelitian ini dilakukan secara eksperimen desain paralel dengan metode matching. Ada 5 kelompok uji, tikus normal, tikus dengan kelebihan asupan lemak, dan pemberian 3 dosis yang berbeda dari ekstrak. Tikus diinduksi dengan kadar trigliserida yang tinggi. Sampel darah diambil di laboratorium setelah 21 hari pada tikus dengan lemak tinggi dan tanpa asupan lemak, dan 3 dosis ekstrak diambil setelah 21 hari kemudian. Hasil dari percobaannya yaitu: (1) tikus normal (29,6), (2) tikus dengan kelebihan asupan lemak (36,4), (3) 10 mg (66,2), (4) 20 mg (72,9) dan (5) 30 mg (67,6). Hasil dianalisis dengan uji T untuk tikus normal dan tikus yang diberi asupan lemak lebih dan hasilnya adalah p = 0,255. 3 dosis hasil Garcinia dianalisis dengan One Way ANOVA-dan hasilnya adalah p = 0,947. Pemberian ekstrak Garcinia dioica strain Wistar tidak menurunkan kadar trigliserida secara signifikan.

---

Cardiovascular disease is the no. 1 cause of death in Indonesia. One of the main problem in cardiovascular disease is hypertriglyceridemia. Garcinia dioica skin extract can be an alternative therapy for elevated triglyceride levels. The research was carried out experimentally the parallel design with matching methods. There are 5 test group; normal rat, rat with excess fat intake, and the administration of 3 different doses of the extract. The rat was inducted with high trigygliceride orally. Blood samples were taken in the laboratory after 21 days on the rat with and without fat intake, and 3 doses of the extract were taken after the next 21 days.

The results of each treatment are: (1) normal rat (29.6), (2) rat with excess fat intake (36.4), (3) 10 mg (66.2), (4) 20 mg (72.9) and (5) 30 mg (67.6). The results were analysed with T test for normal rat and rat that were given excess fat intake and the result is p = 0.255. 3 dose of garcinia results were analysed with One-Way ANOVA and the result is p= 0.947. The administration of extract of Garcinia dioica Wistar strain does not lower triglyceride levels significantly."

"Asam gelugur atau Garcinia atroviridis mengandung bahan aktif flavonoid dan asam hidroksisitrat yang dilaporkan memiliki aktivitas hipolipidemik Penelitian dilakukan untuk mengetahui efek ekstrak kulit dan buah G atroviridis terhadap kadar kolesterol total darah pada tikus galur Wistar yang diberi asupan tinggi lemak Dua puluh lima ekor tikus galur Wistar betina dibagi menjadi lima kelompok perlakukan secara acak Dua kelompok pertama adalah kelompok kontrol dan kelompok percobaan induksi peningkatan kadar kolesterol total dengan pemberian asupan lemak berlebih selama 21 hari Tiga kelompok lainnya adalah kelompok uji dosis yaitu tikus diberikan tambahan asupan tinggi lemak selama 21 hari pertama Kemudian 21 hari berikutnya tikus diberikan asupan ekstrak G atroviridis sambil mempertahankan asupan tinggi lemak Setelah perlakuan selesai sampel darah tikus diambil untuk pemeriksaan kadar kolesterol totalnya Kemudian dilakukan uji statistik terhadap hasil yang didapat Kadar kolesterol total kelompok uji dosis 20 mg lebih rendah secara signifikan dibandingkan kelompok uji dosis 10 mg dan 30 mg Sedangkan kelompok uji dosis 10 mg tidak berbeda bermakna terhadap kelompok uji dosis 30 mg Penelitian ini menunjukkan bahwa asupan G atroviridis dapat menurunkan kadar kolesterol total darah Peningkatan dosis ekstrak tidak selalu meningkatkan efektivitas penurunan kadar kolesterol total.

---

Asam gelugur or Garcinia atroviridis contains active ingredients such as flavonoids and hydroxycitric acid which have been reported to have a hypolipidemic activity This experiment was conducted to examine the effect of G atroviridis fruit and skin extract on total cholesterol level of rats fed a high fat diet Twenty five female Wistar rats were randomly divided into five groups The first two groups are the control group and hyperlipidemia induction group fed with high fat diet for 21 days The rest three groups are dose trials in which rats were fed with high fat diet for the first 21 days And for the next 21 days rats were given G atroviridis extract in three different doses which were 10 mg 20 mg and 30 mg while maintaining high fat diet After all the interventions were done blood samples were obtained for laboratory analysis The results are processed using Post Hoc test Total cholesterol of G atroviridis extract 20 mg dose trial group showed significantly lower results compared with 10 mg dan 30 mg dose group However results from 10 mg dose group are not significantly different compared with 30 mg dose group This study has shown that dietary intake of G atroviridis may decrease total cholesterol level Increased dose of G atroviridis extract does not guarantee an increase in effectiveness of decreasing total cholesterol level."

"Tingginya prevalensi dislipidemia menjadi masalah kesehatan dunia. Diet tinggi lemak merupakan faktor risiko utamanya. Penatalaksanaannya mencakupi pengontrolan profil lipid. Senyawa yang mengintervensi metabolisme lipid dapat menurunkan kadar lipid plasma. Tumbuhan dari marga garcinia mempunyai berbagai metabolit sekunder, seperti xanthones, alkaloids, saponin, and flavonoid. Beberapa senyawa tersebut memiliki bioaktivitas hipolipidemik. Penelitian ini membuktikan pengaruh ekstrak kulit buah Garcinia dioica pada kadar LDL plasma tikus. Penelitian ini menggunakan 25 tikus strain Wistar yang dibagi menjadi 5 kelompok, yaitu kelompok diet standar, kelompok diet tinggi lemak, serta kelompok uji ekstrak Garcinia dioica 10 mg, 20 mg, dan 30 mg. Kelompok diet standar mendapatkan pakan pellet dan 1 ml PTU selama 21 hari untuk acuan tikus normal, sedangkan kelompok diet tinggi lemak diberi tambahan pakan tinggi lemak untuk acuan tikus hiperlipidemia. Kelompok uji mendapat pakan tinggi lemak selama 21 hari untuk induksi hiperlipidemia, dilanjutkan diet tinggi lemak disertai ekstrak Garcinia dioica selama 21 hari berikutnya. Kadar LDL antarkelompok diet dan antarkelompok uji dibandingkan. Nilai pada kelompok uji adalah 17.0±2.45 mg/dL, 26.6±4.16 mg/dL, dan 12.2±2.17 mg/dL. Hubungan kadar LDL dan dosis ekstrak bermakna signifikan (p<0.05). Disimpulkan ekstrak kulit buah Garcinia dioica memiliki efek hipolipidemik dan dosis 150 mg/kg/hari pada tikus yang hiperlipidemia memberikan efek terbaik.

---

Disorder of lipid metabolism, also called hyperlipidemia have been important diseases threating people health. The high fat diet is the main pathogenic cause of it, so regulate blood lipid has been hotspots on research nowadays.Agents from natural products that inhibit and interference lipid metabolism are of theoretical benefit in the treatment of hyperlipidemia. Fruits from genus garcinia is a kind of natural plant product which contains multiple useful components.

This study aims to investigate the effect of Garcinia dioica fruit bark extract on the LDL-C levels. Twenty five experimental rats divided into five experimental groups, including the standart diet group, the high fat diet group, and the high fat diet with 150, 100, 50 mg/(kg·d) Garcinia dioica fruit bark extract groups. The standart diet group were fed standart diet for 21 days to set up normal model rats, while high fat diet group were fed high fat diet for 21 days to set up the model of hyperlipidemia rats.

The other three groups were fed high fat diet for 21 days to set up the model of hyperlipidemia rats and then were fed high fat diet with Garcinia dioica fruit bark extract for another 21 days. The LDL-C lowering efficacy was determined by comparing LDL-C levels among Garcinia dioica groups. The results showed that LDL-C decreased significantly (p<0.05) in all Garcinia dioica groups (high, moderate, low doses). The average LDL-C levels of high dose Garcinia dioica groups is the lowest. It is concluded that the Garcinia dioica fruit bark extract are significant in lowering LDL-C levels."

"ABSTRAK Latar belakang: disglikemia adalah keadaan intoleransi glukosa berupa peningkatan kadar gula darah yang berhubungan dengan risiko penyakit kardiovaskular. Seiring dengan waktu, pada akhirnya diabetes akan menimbulkan kerusakan pada target organ, salah satu yang penting adalah pada sistem organ kardiovaskular, dapat berupa penyakit jantung koroner, kardiomiopati diabetes, penyakit serebrovaskuler, dan penyakit arteri perifer. Diabetes juga meningkatkan risiko terjadinya gagal jantung. Pada kardiomiopati diabetes, proses fibrosis yang masih reversibel sudah mulai terjadi bahkan ketika penderita masih asimtomatik. Pemeriksaan baku emas untuk mendeteksi terjadinya fibrosis miokard secara dini adalah pemeriksaan histopatologi jaringan miokardium melalui biopsi. Akan tetapi pemeriksaan ini sangat invasif dan tidak nyaman bagi subjek. Pemeriksaan yang kemudian berkembang adalah pencitraan menggunakan Cardiac Magnetic Resonance Imaging (CMRI). Akan tetapi pemeriksaan ini cukup mahal, dan tidak tersedia pada semua fasilitas kesehatan. Sementara itu, ST2 adalah penanda enzim jantung yang menggambarkan derajat proses fibrosis yang sedang terjadi pada miokard, terutama pada keadaan gagal jantung. Pemeriksaan menggunakan penanda enzim dapat menjadi alternatif dengan keuntungan lebih murah, dapat terjangkau luas dan mudah tersedia. Tujuan: Mengetahui hubungan antara kadar ST2 serum dengan fibrosis miokard interstisial pada penderita disglikemia. Metode: Pasien disglikemia yang lolos kriteria eksklusi berupa komorbid kardiovaskular akan menjalani pemeriksaan kadar ST2 serum dan T1 relaxation time menggunakan Cardiac MRI. Selanjutnya dilakukan analisis hubungan antara kadar ST2 serum dan T1 relaxation time. Hasil penelitian: Sebanyak 34 pasien diikutsertakan ke dalam penelitian ini. Didapatkan kisaran nilai kadar ST2 serum antara 12.40-53.22 ng/dL (median 19.95 ng/dL). Rerata nilai T1 relaxation time didapatkan sebesar 443.39 ± 113.35 ms. Terdapat korelasi bermakna antara kadar ST2 serum dengan fibrosis diffuse miokardium (Spearman correlation r = -0,547, p < 0.01). Pada analisa multivariat hubungan antara kadar ST2 serum dan T1 relaxation time tidak dipengaruhi oleh faktor perancu yang telah ditetapkan (r = -0,44, p = 0,033). Kesimpulan: Hasil penelitian ini menunjukkan kadar ST2 serum berkolerasi dengan fibrosis diffuse miokardium pada populasi disglikemia.ABSTRACT Background: disglycemia is a state of glucose intolerance include increased blood sugar levels associated with risk of cardiovascular disease. Over time, eventually diabetes will cause damage to the target organ, especially the cardiovascular system, which include coronary heart disease, diabetic cardiomyopathy, diabetes, cerebrovascular disease, and peripheral arterial disease. Diabetes also increases the risk of heart failure. The clinical appearance of the disease is wide ranging from asymptomatic to symptomatic heart failure. Gold standard examination to detect the occurrence of early myocardial fibrosis is histopathological examination of myocardial tissue via biopsy. However, these tests are very invasive and uncomfortable for the subject. Examination which later evolved is imaging using cardiac magnetic resonance imaging (CMRI). However, these tests are quite expensive, and not available at all health facilities. Meanwhile, ST2 is a cardiac enzyme marker that describes the degree of fibrosis process in the myocardium, especially in the state of heart failure. Examination using enzyme markers can be a cheaper alternative, widely accessible and readily available. Aim: Knowing the relationship between serum levels of ST2 with myocardial interstitial fibrosis in disglycemic patients. Methods: Disglycemic patients who passed from the exclusion criteria (cardiovascular comorbid), will undergo a serum ST2 levels and T1 relaxation time using cardiac MRI. Then we analyzed the relationship between serum levels of ST2 and T1 relaxation time. Results: A total of 34 patients were included in this study. The range values of serum ST2 levels were between 12.40-53.22 ng/dL (median 19.95 ng/dL). The mean value of T1 relaxation time were 443.39 ± 113.35 ms. There is a significant correlation between serum levels of ST2 with diffuse myocardial fibrosis (Spearman correlation r = -0.547, p <0:01). Multivariate analysis showed the relationship between serum levels of ST2 and T1 relaxation time is not influenced by confounding factors (r = -0.44, p = 0.033). Conclusion: ST2 serum levels correlates with diffuse myocardial fibrosis on disglycemic population.;Background: disglycemia is a state of glucose intolerance include increased blood sugar levels associated with risk of cardiovascular disease. Over time, eventually diabetes will cause damage to the target organ, especially the cardiovascular system, which include coronary heart disease, diabetic cardiomyopathy, diabetes, cerebrovascular disease, and peripheral arterial disease. Diabetes also increases the risk of heart failure. The clinical appearance of the disease is wide ranging from asymptomatic to symptomatic heart failure. Gold standard examination to detect the occurrence of early myocardial fibrosis is histopathological examination of myocardial tissue via biopsy. However, these tests are very invasive and uncomfortable for the subject. Examination which later evolved is imaging using cardiac magnetic resonance imaging (CMRI). However, these tests are quite expensive, and not available at all health facilities. Meanwhile, ST2 is a cardiac enzyme marker that describes the degree of fibrosis process in the myocardium, especially in the state of heart failure. Examination using enzyme markers can be a cheaper alternative, widely accessible and readily available. Aim: Knowing the relationship between serum levels of ST2 with myocardial interstitial fibrosis in disglycemic patients. Methods: Disglycemic patients who passed from the exclusion criteria (cardiovascular comorbid), will undergo a serum ST2 levels and T1 relaxation time using cardiac MRI. Then we analyzed the relationship between serum levels of ST2 and T1 relaxation time. Results: A total of 34 patients were included in this study. The range values of serum ST2 levels were between 12.40-53.22 ng/dL (median 19.95 ng/dL). The mean value of T1 relaxation time were 443.39 ± 113.35 ms. There is a significant correlation between serum levels of ST2 with diffuse myocardial fibrosis (Spearman correlation r = -0.547, p <0:01). Multivariate analysis showed the relationship between serum levels of ST2 and T1 relaxation time is not influenced by confounding factors (r = -0.44, p = 0.033). Conclusion: ST2 serum levels correlates with diffuse myocardial fibrosis on disglycemic population.;Background: disglycemia is a state of glucose intolerance include increased blood sugar levels associated with risk of cardiovascular disease. Over time, eventually diabetes will cause damage to the target organ, especially the cardiovascular system, which include coronary heart disease, diabetic cardiomyopathy, diabetes, cerebrovascular disease, and peripheral arterial disease. Diabetes also increases the risk of heart failure. The clinical appearance of the disease is wide ranging from asymptomatic to symptomatic heart failure. Gold standard examination to detect the occurrence of early myocardial fibrosis is histopathological examination of myocardial tissue via biopsy. However, these tests are very invasive and uncomfortable for the subject. Examination which later evolved is imaging using cardiac magnetic resonance imaging (CMRI). However, these tests are quite expensive, and not available at all health facilities. Meanwhile, ST2 is a cardiac enzyme marker that describes the degree of fibrosis process in the myocardium, especially in the state of heart failure. Examination using enzyme markers can be a cheaper alternative, widely accessible and readily available. Aim: Knowing the relationship between serum levels of ST2 with myocardial interstitial fibrosis in disglycemic patients. Methods: Disglycemic patients who passed from the exclusion criteria (cardiovascular comorbid), will undergo a serum ST2 levels and T1 relaxation time using cardiac MRI. Then we analyzed the relationship between serum levels of ST2 and T1 relaxation time. Results: A total of 34 patients were included in this study. The range values of serum ST2 levels were between 12.40-53.22 ng/dL (median 19.95 ng/dL). The mean value of T1 relaxation time were 443.39 ± 113.35 ms. There is a significant correlation between serum levels of ST2 with diffuse myocardial fibrosis (Spearman correlation r = -0.547, p <0:01). Multivariate analysis showed the relationship between serum levels of ST2 and T1 relaxation time is not influenced by confounding factors (r = -0.44, p = 0.033). Conclusion: ST2 serum levels correlates with diffuse myocardial fibrosis on disglycemic population.;Background: disglycemia is a state of glucose intolerance include increased blood sugar levels associated with risk of cardiovascular disease. Over time, eventually diabetes will cause damage to the target organ, especially the cardiovascular system, which include coronary heart disease, diabetic cardiomyopathy, diabetes, cerebrovascular disease, and peripheral arterial disease. Diabetes also increases the risk of heart failure. The clinical appearance of the disease is wide ranging from asymptomatic to symptomatic heart failure. Gold standard examination to detect the occurrence of early myocardial fibrosis is histopathological examination of myocardial tissue via biopsy. However, these tests are very invasive and uncomfortable for the subject. Examination which later evolved is imaging using cardiac magnetic resonance imaging (CMRI). However, these tests are quite expensive, and not available at all health facilities. Meanwhile, ST2 is a cardiac enzyme marker that describes the degree of fibrosis process in the myocardium, especially in the state of heart failure. Examination using enzyme markers can be a cheaper alternative, widely accessible and readily available. Aim: Knowing the relationship between serum levels of ST2 with myocardial interstitial fibrosis in disglycemic patients. Methods: Disglycemic patients who passed from the exclusion criteria (cardiovascular comorbid), will undergo a serum ST2 levels and T1 relaxation time using cardiac MRI. Then we analyzed the relationship between serum levels of ST2 and T1 relaxation time. Results: A total of 34 patients were included in this study. The range values of serum ST2 levels were between 12.40-53.22 ng/dL (median 19.95 ng/dL). The mean value of T1 relaxation time were 443.39 ± 113.35 ms. There is a significant correlation between serum levels of ST2 with diffuse myocardial fibrosis (Spearman correlation r = -0.547, p <0:01). Multivariate analysis showed the relationship between serum levels of ST2 and T1 relaxation time is not influenced by confounding factors (r = -0.44, p = 0.033). Conclusion: ST2 serum levels correlates with diffuse myocardial fibrosis on disglycemic population."

"Penyakit kardiovaskuler merupakan penyebab kematian utama penduduk dunia (30%). Untuk menghadapi masalah ini perlu diketahui distribusi penyakit kardiovaskuler terhadap faktor-faktor risikonya secara lebih spesifik. Penelitian ini bertujuan untuk mengetahui gambaran penyakit kardiovaskuler pada pasien rawat inap di Rumah Sakit Jantung dan Pembuluh Darah (RSJPD) Harapan Kita Tahun 2012. Penelitian ini menggunakan data sekunder dari rekam medik RSJPD Harapan Kita menggunakan desain studi cross sectional dengan jumlah sampel 339 orang dianalisis secara univariat. Hasil menunjukkan Ischemic Heart Diseases merupakan penyakit dengan proporsi terbesar yaitu 43,36%. Berdasarkan letak lesi, penyakit jantung memiliki proporsi terbesar yaitu 87,02%. Penyakit kardiovaskuler cenderung mengenai kelompok usia 51-60 tahun dengan proporsi 29,79%. Penyakit kardiovaskuler cenderung menyerang laki-laki dan orang dengan tingkat pendidikan menengah. Diketahui bahwa proporsi pasien hipertensi dan diabetes mellitus cenderung lebih besar di antara pasien penyakit pembuluh darah otak daripada pada pasien penyakit jantung ataupun pasien penyakit pembuluh darah perifer.

---

Cardiovascular disease is the most common death cause (30%) . To face the problem it’s necessary to know the distribution of cardiovascular disease specifically to its risk factors. This research aims to describe the cardiovascular disease among the hospitalized patients in Harapan Kita Cardiovascular Hospital in 2012. This research uses the secondary data from Harapan Kita Cardiovascular Disease medical record and also uses cross sectional design with 339 sample and analyzed in univariate.

The results show that among the cardiovascular diseases in inpatient unit in Harapan Kita Cardiovascular Hospital, Ischemic Heart Diseases is the diseases with the biggest proportion which is 43,36%. According to lesion location, heart disease has the biggest proportion which is 87,02%. Cardiovascular diseases tend to affect the 51-60 years old group of age by 29,79% among other age groups. Cardiovascular diseases tend to affect men and those who have middle educational level. The results also show that proportion of patients with hypertension and Diabetes Melitus tends to be bigger among cererovascular diseases patients than heart diseases patients or peripheral vascular diseases patients."

"ABSTRAKNama : Alifiah RachmaProgram Studi : Ilmu Kesehatan MasyarakatJudul : Pengembangan Aplikasi Daring Sistem Monitoring dan Evaluasi FaktorRisiko Penyakit Jantung dan Pembuluh DarahPembimbing : Dr. Artha Prabawa, SKM, M.SiPenyakit jantung dan pembuluh darah PJPD , salah satu Penyakit Tidak Menular,merupakan penyebab kematian terbesar secara global di seluruh negara. Prevalensi PJPDdi Indonesia tergolong tinggi. Akan tetapi skrining atau deteksi dini faktor risiko PJPDmasih rendah. Oleh karena itu, penelitian ini bertujuan untuk membangun pengembanganaplikasi daring dalam jaringan sistem monitoring dan evaluasi faktor risiko penyakitjantung dan pembuluh darah yang terintegrasi dengan surveilans dan sistem informasiPTM dan memudahkan penduduk Indonesia melakukan deteksi dini faktor risiko PJPD.Pengembangan sistem pada penelitian ini menggunakan System Development Life Cycle SDLC metode Rapid Application Development dengan model sistem pengembanganiterative penambahan .Hasil penelitian ini adalah Prototype aplikasi daring sistem monitoring dan evaluasifaktor risiko penyakit jantung dan pembuluh darah PJPD yang bernama SEHATJANTUNGKU. Prototype sistem ini berbasis website responsive online yangmemudahkan pengguna aplikasi mengakses sistem ini dimana saja dan melalui berbagaijenis platform. Kesimpulan dari penelitian ini adalah pengembangan aplikasi daringsistem monitoring dan evaluasi membantu pengelola program PTM dan stakeholderuntuk monitoring, evaluasi, dan membuat kebijakan.Kata kunci:Penyakit Tidak Menular, faktor risiko PJPD, deteksi dini, RAD, monev

---

ABSTRACTName Alifiah RachmaStudy Program Public Health ScienceTitle Online Application Development of Monitoring and EvaluatingSystem of the Cardiovascular Disease Risk FactorCounsellor Dr. Artha Prabawa, SKM, M.SiBackground Cardiovascular Disease CVD is one of Non communicable Diseaseswhich cause the biggest number of death all over the world. The prevalence ofcardiovascular disease in Indonesia is high, but the screening or earlier detection of riskfactor of CVD is still low. In this context, this research is aimed to build online applicationdevelopment of monitoring and evaluating system of the CVD risk factor which isintegrated with the surveillance and NCD information system to facilitate Indonesian tohave earlier detection of CVD risk factor. Method System development in research usingSystem Development Life Cycle SDLC method of Rapid Application Development withchoice of iterative system model. Results the prototype of online application developmentof monitoring and evaluating system of the CVD risk factor is named SEHATJANTUNGKU. This prototype is online responsive web based which facilitate the usersto access this system anywhere and by using many platforms. Conclusions the onlineapplication development of monitoring and evaluating system of the CVD risk factor willhelp the NCD program manager and stakeholders to monitor, evaluate, and createrelated policies.Keywords NCD, CVD risk factor, early detection, RAD, monitoring and evaluating"

"ABSTRAKPenyakit kardiovaskuler adalah penyakit serius yang mematikan di mana seperempat kematian yang terjadi ternyata disebabkan oleh penyakit ini. Sementara itu, di negara berkembang seperti Indonesia kualitas layanan kesehatan masih rendah, ditandai dengan kurangnya tenaga dokter pada daerah-daerah rural dan terpencil. Kondisi ini menjadi motivasi perlunya merancang inovasi teknologi telemedical yang berfungsi membantu dokter melakukan diagnosis dan pengobatan penyakit kardiovaskuler. Penelitian ini mengusulkan sebuah sistem berbasis teknologi machine-to-machine M2M untuk mengecek kesehatan pasien yang akan melaporkan hasilnya ke dokter jantung secara jarak jauh melalui aplikasi website dan aplikasi mobile, yang diberi nama My Kardio. Desain dari sistem ini adalah terdiri dari tiga bagian utama yaitu bagian pasien patient site yang terdiri dari sensor-sensor dan gateway, bagian server server site yaitu server aplikasi web dan mobile yang terletak di cloud internet, dan bagian dokter doctor site yaitu aplikasi web dan mobile untuk dokter agar dokter dapat melakukan pengecekan dan diagnosis terhadap pasien secara online. Sistem ini dilengkapi dengan sistem prediksi auto-rekomendasi untuk memberikan rekomendasi kepada dokter dalam menentukan diagnosis penyakit yang diderita pasien. Sistem auto-rekomendasi ini dibangun dengan algoritma k-Nearest Neighbors kNN yang terbukti cukup baik performansinya dalam hal akurasi dan kecepatan. Uji coba telah dilakukan pada empat lokasi di daerah pinggiran Jakarta yaitu Kampung Banjarsari 10 pasien , Cibubur 15 pasien , Cimanggis 37 pasien , dan Pancoran 23 pasien pada total sejumlah 85 pasien. Evaluasi kuantitatif menghasilkan rata-rata akurasi prediksi sistem auto-rekomendasi adalah 76,47 , waktu pemrosesan sistem auto-rekomendasi 1 detik, dan performansi waktu transfer data dari lokasi pemeriksaan ke server M2M adalah 8,97 detik. Evaluasi secara kualitatif dilakukan melalui wawancara dokter spesialis jantung, dan diperoleh hasil bahwa aplikasi My Kardio sangat membantu terutama untuk daerah-daerah yang kekurangan dokter spesialis jantung; dan juga bermanfaat untuk kota besar di mana akses pasien ke dokter jantung juga terkendala oleh waktu praktek dokter yang terbatas dan kemacetan. Kata kunci:Machine-to-machine, penyakit kardiovaskuler, k-Nearest Neighbors.

---

ABSTRACTCardiovascular disease is a deadly disease which one-fourth of deaths are caused by this disease. Meanwhile, in developing country like Indonesia, the quality of health services is still low, marked by the lack of doctors to serve patients. This condition gives the motivation about the need for a new innovation to improve the life expectancy of cardiovascular patients in Indonesia, with the help of technology. This research proposes a machine-to-machine M2M technology-based system to check the health of patients which will report the results to the cardiologist remotely through the web and mobile applications, named My Kardio. The design of this system is composed of three main parts, the first one is patient site consisting of sensors and gateways, then server site which is web and mobile application server located in the Internet cloud, and the last is doctor site: web and mobile application for doctors to enable doctors checking and diagnosing patients online. The system is equipped with an auto - recommendation prediction system to provide recommendations to physicians in determining the diagnosis of illness suffered by the patient. This auto-recommendation system is built on the k-Nearest Neighbors kNN algorithm that has been proven with good accuracy and fast. Trials have been performed in four locations in the suburbs of Jakarta: Kampung Banjarsari 10 patients , Cibubur 15 patients , Cimanggis 37 patients , and Pancoran 23 patients of the total 85 patients. Quantitative analysis results are, first the prediction accuracy of the auto- recommendation system is 76.47 on average, then the processing time of auto- recommendation system is 1 second, and last, the duration of data transfer time from location to M2M server is 8.97 seconds. Qualitative analysis was made with cardiologists interviews, which results that My Kardio application is very helpful especially in remote areas which lacking of cardiologists, even for big cities where patients rsquo; access to cardiologists is a problem due to limited clinic time and traffic jams. "